ARTA
KBIO

A.R.T. Advisors’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

A.R.T. Advisors’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-30,626
Closed -$58K – 1987
2015
Q3 		$58K Buy
+30,626
New +$80.8K ﹤0.01% 1283
2014
Q2 		– Sell
-1,946
Closed -$42K – 1798
2014
Q1 		$42K Buy
+1,946
New +$56.4K ﹤0.01% 1284

Other funds holding KBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

A.R.T. Advisors's KBIO Position: Q4 2015 in Review

A.R.T. Advisors sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q4 2015, closing a stake of 30,626 shares — an estimated $58K sold.

A.R.T. Advisors first reported a position in KBIO in Q1 2014 and held it in 2 quarters. The position peaked at $58K in Q3 2015. 17 funds tracked by Wall St. Rank hold KBIO as of Q4 2015.

  • A.R.T. Advisors reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q4 2015 after selling out during the quarter.
  • A.R.T. Advisors sold 30,626 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q4 2015, an estimated $58K.
  • A.R.T. Advisors first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q1 2014 and held it in 2 quarters.
  • A.R.T. Advisors's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $58K in Q3 2015.
  • 17 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q4 2015.

Based on A.R.T. Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.